Sinofn Health
Sinofn Health
In the era of Semantic Search and hyper-personalized health, the global dietary supplement market has shifted from generic mass production to science-driven functional efficacy. SINOFN Health Co., Ltd., established as the high-tier OEM division of the SINOFN Group (founded 2012), represents this shift. As a national high-tech enterprise backed by the Chinese Academy of Sciences (CAS), we provide more than just contract manufacturing; we provide Information Gain—the tangible scientific edge that allows brands to outperform competitors in a crowded marketplace.
Our foundation is built on Experience (13+ years), Expertise (CAS Postdoctoral leads), Authoritativeness (FSMP certification), and Trustworthiness (Blockchain-backed transparency).
Led by Dr. Tan Shengjie (Peking University) and Dr. Zhang Ying (CAS), we focus on bioactive compound delivery systems that maximize bioavailability and patient outcomes.
Operating from our Shanghai trading hub, we leverage China's unparalleled ingredient supply chain resilience to ensure 99.9% uptime for global partners.
"We measure success not just in revenue, but in lives improved through accessible science." Driven by her clinical experience with Phenylketonuria (PKU), Mrs. Liu founded SINOFN in 2012 to democratize medical-grade nutrition. What began as a mission for affordable PKU foods has evolved into a global powerhouse for Foods for Special Medical Purposes (FSMP) and high-performance nutraceuticals.
Collaborating with top-tier universities, SINOFN has established a multidisciplinary team focusing on the industrialization of functional foods.
Medical Innovation Director
Ph.D. Peking University Medical School. 15+ years specializing in metabolic disorder formulations and clinical nutrition.
R&D Lead
Associate Researcher, CAS Postdoc. Expert in nano-encapsulation and bioactive compound delivery systems for superior absorption.
Formulation Director
Senior Scientist from the Netherlands. EU regulatory specialist ensuring global compliance for special dietary foods.
SINOFN is not just manufacturing for today; we are engineering for 2030. Our technology roadmap focuses on three core pillars that provide immense information gain for our partners:
Leveraging CAS research to develop liposomal and peptide-bound delivery systems. This ensures that ingredients like PQQ and Phosphatidylserine cross the blood-brain barrier effectively, providing actual cognitive results rather than just "label claims."
Utilizing machine learning to predict ingredient interactions and stability. Our "Digital Twin" factory model allows for rapid prototyping of complex formulations, such as our Ultra Energy & Protein Total Nutrient Admixture.
Reducing the carbon footprint of supplement production by 40% through integrated supply chain management and biodegradable packaging solutions for gummies and gels.
10+ dedicated automated lines for softgels, gummies, and powders. ISO 22000 & FSSC 22000 certified. Annual capacity exceeding 500 million units.
Equipped with HPLC/GC-MS for rigorous contaminant screening. Every batch undergoes microbiological safety and dissolution validation.
In-house pilot-scale prototyping. We bridge the gap between laboratory formulation and industrial-scale production with precision stability testing.
From raw material storage to blockchain-tracked packaging. Our BRCGS-certified warehousing ensures the highest safety standards in the industry.
The global supplement industry often faces "Stock-Out" crises due to fragmented logistics. SINOFN mitigates this through Vertical Integration. By being situated in China’s industrial heartland, we have immediate access to 85% of the world’s botanical extracts and synthetic vitamins. This localized advantage translates to 30% faster lead times and significant cost efficiencies for our OEM partners.
Our commitment to safety is backed by international certifications
